Tardive dyskinesia (TD) is an involuntary neurological movement problem caused by the utilization of dopamine receptor-impeding medications that are endorsed to treat specific mental or gastrointestinal circumstances. The global tardive dyskinesia treatment market is focused on the diagnosis of neuromuscular movements in the mouth, lips, and tongue.

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Type

7 Market Segmentation by Application

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape